Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2010 1
2011 1
2012 3
2013 2
2014 1
2015 2
2016 4
2017 4
2018 4
2019 2
2020 3
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Design of Materials for Bone Tissue Scaffolds.
Boccaccio A. Boccaccio A. Materials (Basel). 2021 Oct 12;14(20):5985. doi: 10.3390/ma14205985. Materials (Basel). 2021. PMID: 34683577 Free PMC article.
Metals Biotribology and Oral Microbiota Biocorrosion Mechanisms.
Contuzzi N, Casalino G, Boccaccio A, Ballini A, Charitos IA, Bottalico L, Santacroce L. Contuzzi N, et al. Among authors: boccaccio a. J Funct Biomater. 2022 Dec 23;14(1):14. doi: 10.3390/jfb14010014. J Funct Biomater. 2022. PMID: 36662061 Free PMC article. Review.
Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds.
Cantore S, Crincoli V, Boccaccio A, Uva AE, Fiorentino M, Monno G, Bollero P, Derla C, Fabiano F, Ballini A, Santacroce L. Cantore S, et al. Among authors: boccaccio a. Endocr Metab Immune Disord Drug Targets. 2018;18(5):466-469. doi: 10.2174/1871530318666180423102905. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29692270 Review.
Optimization of Cobalt-Chromium (Co-Cr) Scaffolds for Bone Tissue Engineering in Endocrine, Metabolic and Immune Disorders.
Rodríguez-Montaño ÓL, Vaiani L, Boccaccio A, Uva AE, Lo Muzio L, Spirito F, Dioguardi M, Santacroce L, Cosola MD, Cantore S, Ballini A. Rodríguez-Montaño ÓL, et al. Among authors: boccaccio a. Endocr Metab Immune Disord Drug Targets. 2023 Nov 8. doi: 10.2174/0118715303258126231025115956. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37946349
32 results